DEA proposes listing three steroids under Schedule III

The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

The American Pharmacists Association announced the inclusion of pharmacist-backed PBM reform in Congress’ end of the year spending package.